Bringing science to health and nutrition

ΔG is the first example of an entirely new food group that offers significant commercial opportunities in a wide range of complementary market areas.

This innovative nutraceutical has already shown promise in improving physical and cognitive performance in a wide range of environments, from sports track to battlefield. Studies are also underway to investigate the potential effects of ΔG in a range of clinical conditions.

The synthesis and manufacture of ΔG draws directly on pioneering research carried out at the University of Oxford and the National Institutes of Health.

With trials already at an advanced stage, ΔG has potential use in a wide range of commercial products that are set to reach the market as early as 2014. A global patent portfolio is currently being developed to protect ΔG and its manufacture as well as its areas of application.

Learn more about this unique investment opportunity with dramatic upside potential